
HPK1-IN-17 is a мощный and селективный ингибитор of HPK1. Hematopoietic progenitor киназы 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP киназы киназы киназы kinases (MAP4Ks) family. HPK1-IN-17 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019238067A1, compound 73).
HPK1-IN-17 is a potent and selective inhibitor of HPK1. Hematopoietic progenitor kinase 1 (HPKl) originally cloned from hematopoietic progenitor cells is a member of MAP kinase kinase kinase kinases (MAP4Ks) family. HPK1-IN-17 is useful in researching, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer (extracted from patent WO2019238067A1, compound 73).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.